3
Announcements
Trials
Browse
Landscape
Status
Completed
2
Terminated
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
19
Observational
2
Sponsor
Cancer Type
Other hematologic neoplasm
2
Lymphoid
2
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, B-Cell
1
Interventions
Surveys and Questionnaires
286
Blood Specimen Collection
145
Gene Expression Profiling
96
Interviews as Topic
83
Immunohistochemistry
78
Polymerase Chain Reaction
64
Surgical Procedures, Operative
62
Magnetic Resonance Spectroscopy
58
Microarray Analysis
55
Flow Cytometry
53
Radiotherapy
49
Amplified Fragment Length Polymorphism Analysis
48
Drug Therapy
46
Observation
45
Biopsy
42
Reverse Transcriptase Polymerase Chain Reaction
39
Bevacizumab
39
Data Collection
35
Sorafenib
29
Psychiatric Rehabilitation
29
Nivolumab
28
palbociclib
26
In Situ Hybridization, Fluorescence
26
Rituximab
25
Therapeutics
24
Neoadjuvant Therapy
24
Hepatectomy
24
Docetaxel
24
Colonoscopy
24
Sunitinib
23
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
Observational
×
idelalisib
×
Clear all
NCT03545035
2022-05-12
LLC178
Gruppo Italiano Malattie EMatologiche dell'Adulto
Completed
104 enrolled
NCT03582098
2019-04-12
RETRO-idel
Gilead Sciences
Completed
112 enrolled